The study of inhibiting systematic inflammatory response syndrome by applying xenogenic (porcine) acellular dermal matrix on second-degree burns

被引:29
作者
Feng, Xiangsheng
Shen, Rui
Tan, Jiaju
Chen, Xiaodong
Pan, Yingen
Ruan, Shubin
Zhang, Fenggang
Lin, Zepeng
Zeng, Yinghong
Wang, Xiaoping
Lin, Yan
Wu, Qiuhe [1 ]
机构
[1] Shandong Univ, Clin Coll, Jinan Cent Hosp, Dept Plast & Burn Surg, Jinan 250013, Peoples R China
[2] First Peoples Hosp Foshan, Dept Plast & Burn Surg, Foshan 528000, Peoples R China
[3] Peoples Hosp Qidong, Dept Plast & Burn Surg, Qidong 226200, Peoples R China
关键词
xenogenic (porcine) acellular dermal matrix; C-reactive protein (CRP); systematic inflammatory response syndrome (SIRS); C-REACTIVE PROTEIN; THICKNESS BURNS; INDICATOR; PROCALCITONIN; INFECTION; SEPSIS;
D O I
10.1016/j.burns.2006.08.011
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Objective: To investigate the influence of xenogenic (porcine) acellular dermal matrix on the systematic inflammatory reaction syndrome (SIRS), and the reaction of burn patients to tissue damage upon application to second-degree burn wounds. Method: Seventy-two cases of patients with acute second-degree burns were enrolled in the study. According to the total burn surface area (TBSA) and the treatment methods, we randomly divided the patients into four groups. Group A (treatment group): patients with less than 30% TBSA covered with xenogenic acellular dermal matrix. Group B (control group): patients with less than 30% TBSA covered with betadine ointment gauzes. Group C (treatment group): patients with more than 30% TBSA covered with porcine acellular dermal matrix. Group D (control group): patients with more than 30% TBSA covered with betadine ointment gauzes. Serum level of C-reactive protein (CRP) was measured by single radial immunodiffusion method on 1, 4, 7 and 14 days postburn. Results: The serum level of CRP in group A was significantly less than that of in group B (P < 0.05) on days 4,7 and 14. The serum level of CRP in group C increased slowly, descended quickly and was significantly less than that of in group D on days 4, 7 and 14. Conclusion: The application of xenogenic (porcine) acellular dermal matrix on second-degree burn wound can decrease serum level of CRP of the patients, which may play an important role in reducing SIRS and sepsis incidence. (C) 2006 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:477 / 479
页数:3
相关论文
共 15 条
[1]
CHEN H, 2003, GUANGXI MED J, V25, P502
[2]
A class of counterexamples concerning an open problem [J].
Chen, PX ;
Lu, SM .
ACTA MATHEMATICA SINICA-ENGLISH SERIES, 2005, 21 (01) :9-12
[3]
Health-promoting workplaces - international settings development [J].
Chu, C ;
Breucker, G ;
Harris, N ;
Stitzel, A ;
Gan, XF ;
Gu, XQ ;
Dwyer, S .
HEALTH PROMOTION INTERNATIONAL, 2000, 15 (02) :155-167
[4]
FENG X, 2002, J 1 MILITARY MED U, V22, P844
[5]
Control of hypertrophic scar from inception by using xenogenic (porcine) acellular dermal matrix (ADM) to cover deep second degree burn [J].
Feng, XS ;
Tan, JJ ;
Pan, YG ;
Wu, QH ;
Ruan, SB ;
Shen, R ;
Chen, XD ;
Du, YJ .
BURNS, 2006, 32 (03) :293-298
[6]
OUTPATIENT MANAGEMENT OF PARTIAL-THICKNESS BURNS - BIOBRANE VERSUS 1-PERCENT SILVER SULFADIAZINE [J].
GERDING, RL ;
EMERMAN, CL ;
EFFRON, D ;
LUKENS, T ;
IMBEMBO, AL ;
FRATIANNE, RB .
ANNALS OF EMERGENCY MEDICINE, 1990, 19 (02) :121-124
[7]
SKIN SUBSTITUTES IN THE TREATMENT OF DEEP PARTIAL SKIN THICKNESS BURNS IN CHILDREN - CLINICAL-EXPERIENCE AND LONG-TERM RESULTS [J].
GRISOLIA, GA ;
PELLI, P ;
PINZAUTI, E ;
PANOZZO, G ;
STUTO, A ;
DANTI, DA ;
BILLI, G ;
PAMPALONI, A .
BURNS, 1991, 17 (01) :52-55
[8]
Peng Yi-Zhi, 2005, Zhonghua Shao Shang Za Zhi, V21, P12
[9]
C-reactive protein as an indicator of sepsis [J].
Povoa, P ;
Almeida, E ;
Moreira, P ;
Fernandes, A ;
Mealha, R ;
Aragao, A ;
Sabino, H .
INTENSIVE CARE MEDICINE, 1998, 24 (10) :1052-1056
[10]
C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome [J].
Sierra, R ;
Rello, J ;
Bailén, MA ;
Benítez, E ;
Gordillo, A ;
León, C ;
Pedraza, S .
INTENSIVE CARE MEDICINE, 2004, 30 (11) :2038-2045